Platelets and aging I.-Aggregation, arachidonate metabolism and antioxidant status

Thrombosis Research

Volumn 49, Issue 3, 1988, Pages 331-342

  Vericel, E ^a,d   Croset, M ^a   Sedivy, P ^b   Courpron, Ph ^c   Dechavanne, M ^a   Lagarde, M ^a,d  

^a INSERM   (France)

^b SANOFI   (France)

^c Maison de Sante et de Cure Médicale A Charial ^*  (France)

^d UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

elderly people; platelet functions; thromboxane A2; urinary prostanoids; vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; THROMBOXANE A2; THROMBOXANE B2;

HUMAN; HUMAN CELL; NORMAL HUMAN; THROMBOCYTE AGGREGATION;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; 6-KETOPROSTAGLANDIN F1 ALPHA; ADULT; AGED; AGED, 80 AND OVER; AGING; ARACHIDONIC ACID; ARACHIDONIC ACIDS; BLOOD PLATELETS; COMPARATIVE STUDY; FATTY ACIDS, UNSATURATED; HUMAN; HYDROXYEICOSATETRAENOIC ACIDS; PLATELET AGGREGATION; SUPPORT, NON-U.S. GOV'T; THROMBOXANE B2; VITAMIN E;

EID: 0023888428     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(88)90313-1     Document Type: Article

References (34)

1. Nationwide cerebrovascular disease morbidity study
2. Acetylsalicylic acid bleeding time and age
3. Platelet survival studies in man with special reference to thrombosis and atherosclerosis
4. Enhanced in vivo platelet “release reaction” in old healthy individuals
5. Evaluations of some platelet parameters in a group of elderly people
6. Sex and age differences in human platelet aggregation
7. Platelet aggregation stroke and transient ischemic attack in middle-aged and elderly people
8. Platelets physiology and abnormality of function
9. The prostanoids in hemostasis and thrombosis
10. Thromboxanes a new group of biologically active compounds derived from prostaglandin endoperoxides
11. Arachidonate lipoxygenase in blood platelets
12. Altered lipoxygenase metabolism and decreased glutathione peroxidase activity in platelets from selenium-deficient rats
13. Human arterial and venous tissues generate prostacyclin (prostaglandin X) a potent inhibitor of platelet aggregation
14. Biological importance of prostacyclin
15. Eicosanoid biosynthesis and platelet function with advancing age
16. Aggregation of blood platelets by adenosine diphosphate and its reversal
17. A simple and efficient method for platelet isolation from their plasma
18. Differential effect of external calcium on the oxygenated metabolism of endogenous and exogenous arachidonic acid in platelets
19. Inhibition of thrombin-induced platelet arachidonic acid release by 15-hydroperoxy-arachidonic acid
20. Radioimmunoassay of prostaglandins F1α E1 and E2 in human plasma
21. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus
22. Enzyme immunoassays of eicosanoids using acetyl choline esterase as label an alternative to radioimmunoassay
23. Formation of prostaglandins during the aggregation of human blood platelets
24. Age-related changes in human platelet function in vitro
25. Increased lipid peroxidation in platelets from elderly people
26. Platelets from aged rats aggregate more but are more sensitive to prostacyclin
27. Changes in arachidonate metabolism in aortas and platelets in aging rats
28. Altered lipoxygenase metabolism and decreased glutathione peroxidase activity in platelets from selenium-deficient rats
29. Altered arachidonic acid metabolism in platelets and aortas from selenium-deficient rat
30. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation
31. A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2
32. Changes in vitamin E concentrations in human plasma and platelets with age
33. The effects of vitamin E on arachidonic acid metabolism
34. Effect of vitamin E on platelet aggregation in diabetes mellitus